Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
c ebpβ-lip drug

c ebpβ-lip drug C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module C/EBPβ-LIP induces cancer-type metabolic reprogramming

C EBP LIP induces cancer type metabolic reprogramming by regulating the let 7 LIN28B circuit in mice Communications Biology Increasing intratumor C EBP LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer Journal of Experimental & Clinical Cancer Research Springer Nature Link C EBP: The structure, regulation, and its roles in inflammation related diseases ScienceDirect A screening strategy for the discovery of drugs that reduce C EBP LIP translation with potential calorie restriction mimetic properties Scientific Reports

SKU: 46611781141 · From webdevsolutions.tech

4.2
USD24.22 USD63.22

Pay in 4 interest-free payments of $6.05 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 17 - Aug 22

Description

and Hagiwara, H

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module C/EBP-LIP induces cancer-type metabolic reprogramming

nh gi gi c, thng hiu Angel's Liquid l thng hiu m phm n t Hn Quc, ni ting vi cc sn phm dng trng chuyn su, c bit l dng sn phm cha hot cht Glutathione vi nng cao, hng n mc tiu mang li hiu qu lm sng da nhanh chng

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module C/EBP-LIP induces cancer-type metabolic reprogramming

May Help Reduce Oxidative Stress Oxidative stress is a natural process that contributes to cellular aging over time

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module C/EBP-LIP induces cancer-type metabolic reprogramming

Aortic pulse wave velocity as a measure of cardiovascular risk in chronic obstructive pulmonary disease: two-year follow-up data from the ARCADE study

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module C/EBP-LIP induces cancer-type metabolic reprogramming
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products